[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI98830B - Process for the preparation of bifunctional proteins - Google Patents

Process for the preparation of bifunctional proteins

Info

Publication number
FI98830B
FI98830B FI881743A FI881743A FI98830B FI 98830 B FI98830 B FI 98830B FI 881743 A FI881743 A FI 881743A FI 881743 A FI881743 A FI 881743A FI 98830 B FI98830 B FI 98830B
Authority
FI
Finland
Prior art keywords
preparation
bifunctional proteins
bifunctional
proteins
Prior art date
Application number
FI881743A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI881743A0 (en
FI98830C (en
FI881743A (en
Inventor
Paul Habermann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI881743A0 publication Critical patent/FI881743A0/en
Publication of FI881743A publication Critical patent/FI881743A/en
Publication of FI98830B publication Critical patent/FI98830B/en
Application granted granted Critical
Publication of FI98830C publication Critical patent/FI98830C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI881743A 1987-04-16 1988-04-14 Process for the preparation of bifunctional proteins FI98830C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3712985 1987-04-16
DE19873712985 DE3712985A1 (en) 1987-04-16 1987-04-16 BIFUNCTIONAL PROTEINS

Publications (4)

Publication Number Publication Date
FI881743A0 FI881743A0 (en) 1988-04-14
FI881743A FI881743A (en) 1988-10-17
FI98830B true FI98830B (en) 1997-05-15
FI98830C FI98830C (en) 1997-08-25

Family

ID=6325799

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881743A FI98830C (en) 1987-04-16 1988-04-14 Process for the preparation of bifunctional proteins

Country Status (20)

Country Link
EP (1) EP0288809B1 (en)
JP (1) JP2667193B2 (en)
KR (1) KR970000187B1 (en)
AR (1) AR242991A1 (en)
AT (1) ATE79135T1 (en)
AU (1) AU613022B2 (en)
CA (1) CA1322157C (en)
DE (2) DE3712985A1 (en)
DK (1) DK170741B1 (en)
ES (1) ES2033981T3 (en)
FI (1) FI98830C (en)
GR (1) GR3006141T3 (en)
HU (1) HU204303B (en)
IE (1) IE61574B1 (en)
IL (1) IL86086A (en)
NO (1) NO176922C (en)
NZ (1) NZ224247A (en)
PH (1) PH25327A (en)
PT (1) PT87237B (en)
ZA (1) ZA882659B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5073627A (en) * 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
US5108910A (en) * 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
JP3115318B2 (en) * 1989-08-22 2000-12-04 イミュネックス・コーポレーション Fusion protein containing GM-CSF and IL-3
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
EP1037927B1 (en) 1997-12-08 2004-05-19 Lexigen Pharmaceuticals Corp. Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
ATE316982T1 (en) 1999-08-09 2006-02-15 Lexigen Pharm Corp MULTIPLE CYTOKINE ANTIBODIES COMPLEXES
JP4553290B2 (en) * 1999-11-30 2010-09-29 塩野義製薬株式会社 Chemokine SLC-IL2 fusion protein and its gene
DE60122286T2 (en) 2000-02-11 2007-08-02 Merck Patent Gmbh INCREASING THE CIRCULATORY HALF-TIME OF ANTIBODY-BASED FUSION PROTEINS
KR20090010127A (en) 2001-03-07 2009-01-28 메르크 파텐트 게엠베하 Expression technology for proteins containing a hybrid isotype antibody moiety
WO2002079415A2 (en) 2001-03-30 2002-10-10 Lexigen Pharmaceuticals Corp. Reducing the immunogenicity of fusion proteins
BR0209177A (en) 2001-05-03 2004-10-05 Merck Patent Gmbh Recombinant tumor specific antibody and use
CN102180944A (en) 2001-10-10 2011-09-14 诺和诺德公司 Remodeling and glycoconjugation of peptides
EP2354791A1 (en) 2001-12-04 2011-08-10 Merck Patent GmbH Immunocytokines with modulated selectivity
BRPI0317376B8 (en) 2002-12-17 2021-05-25 Merck Patent Gmbh antibody-il2 fusion protein designated as hu14.18-il2, uses thereof, vector and pharmaceutical composition
DE602004031341D1 (en) 2003-07-21 2011-03-24 Transgene Sa MULTIFUNCTIONAL CYTOKINE
JP4842128B2 (en) * 2003-07-21 2011-12-21 トランジェーヌ、ソシエテ、アノニム Novel multifunctional cytokine
WO2010001414A1 (en) * 2008-07-03 2010-01-07 Lupin Limited Expression of heterologous proteins in bacterial system using a gm-csf fusion tag

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0158198A1 (en) * 1984-03-29 1985-10-16 Takeda Chemical Industries, Ltd. DNA and use thereof
WO1985004673A1 (en) * 1984-04-10 1985-10-24 Takeda Chemical Industries, Ltd. Novel dna and its use
DE3419995A1 (en) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt GENE TECHNOLOGICAL METHOD FOR PRODUCING HUMAN INTERLEUKIN-2 AND MEANS FOR CARRYING OUT THIS METHOD
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
JPS61128889A (en) * 1984-11-27 1986-06-16 Green Cross Corp:The Recombinant dna and transformant by same
JPH0646957B2 (en) * 1985-03-11 1994-06-22 武田薬品工業株式会社 Method for producing interleukin-2
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
DE3541856A1 (en) * 1985-11-27 1987-06-04 Hoechst Ag EUKARYOTIC FUSION PROTEINS, THEIR PRODUCTION AND USE, AND MEANS FOR CARRYING OUT THE PROCESS
DE3545568A1 (en) * 1985-12-21 1987-07-16 Hoechst Ag GM-CSF-PROTEIN, ITS DERIVATIVES, PRODUCTION OF SUCH PROTEINS AND THEIR USE

Also Published As

Publication number Publication date
DK209188D0 (en) 1988-04-15
IE61574B1 (en) 1994-11-16
JP2667193B2 (en) 1997-10-27
AU1466188A (en) 1988-10-20
HUT47319A (en) 1989-02-28
EP0288809B1 (en) 1992-08-05
CA1322157C (en) 1993-09-14
PT87237A (en) 1988-05-01
JPS63301898A (en) 1988-12-08
IE881146L (en) 1988-10-16
EP0288809A1 (en) 1988-11-02
NO881658L (en) 1988-10-17
HU204303B (en) 1991-12-30
DK209188A (en) 1988-10-17
PH25327A (en) 1991-04-30
FI881743A0 (en) 1988-04-14
NZ224247A (en) 1990-04-26
PT87237B (en) 1992-07-31
NO176922C (en) 1995-06-21
AR242991A1 (en) 1993-06-30
DE3873397D1 (en) 1992-09-10
AU613022B2 (en) 1991-07-25
FI98830C (en) 1997-08-25
IL86086A0 (en) 1988-09-30
DK170741B1 (en) 1996-01-08
KR970000187B1 (en) 1997-01-06
GR3006141T3 (en) 1993-06-21
DE3712985A1 (en) 1988-11-03
NO176922B (en) 1995-03-13
FI881743A (en) 1988-10-17
ES2033981T3 (en) 1993-04-01
IL86086A (en) 1995-01-24
KR880012760A (en) 1988-11-29
NO881658D0 (en) 1988-04-15
ATE79135T1 (en) 1992-08-15
ZA882659B (en) 1988-10-14

Similar Documents

Publication Publication Date Title
FI98830B (en) Process for the preparation of bifunctional proteins
FI882007A (en) Process for the preparation of steroid-5-reductase inhibitors
PT86600A (en) PROCESS FOR THE PREPARATION OF ANTICOAGULANT PEPTIDES
FI981380A (en) Process for Preparation of HCV Polypeptides
FI892058A0 (en) Process for the preparation of phenol
NO172447C (en) PROCEDURE FOR B-AVERMECTIN PREPARATION
FI881303A (en) Process for the preparation of ibuprofen
FI872769A (en) Process for the preparation of alpha-monoolefins
FI104171B (en) Process for the preparation of mono-N-alkylated polyazamacrocyclic compounds
FI93215C (en) Process for the preparation of therapeutically useful aminoalkoxyphenyl derivatives
FI880467A (en) Process for the preparation of therapeutically useful substituted 3,4-dihydro-2H-benzopyrans
FI902316A0 (en) Process for the preparation of therapeutically-substituted dihydropyrrolizine compounds
FI102270B1 (en) Process for the preparation of diets
FI895663A0 (en) Process for the preparation of chlorofluorobenzene or difluorobenzene
FI92065C (en) Process for the preparation of pharmaceutical piperidine derivatives
FI93119B (en) Process for the preparation of novel thieno-triazolo-diethepines
PT87857A (en) PROCESS FOR THE PREPARATION OF NOVEL IMMUNOSSUPRESSANT PEPTIDES
FI92188C (en) Process for the preparation of therapeutically useful phenoxyalkylpyrocatechol derivatives
FI901606A0 (en) Process for the preparation of sulfonyl derivatives of thieno-trizolidodiazepines
NO174085C (en) Process for the preparation of sucralfate preparations
FI892144A (en) Process for the preparation of 5-C-hydroxymethylaldohexose-based compounds
FI93442B (en) Process for the preparation of new cysteine derivatives
FI88294C (en) Process for the preparation of azetidinones
PT87732A (en) PROCESS FOR THE PREPARATION OF (E) - (P-FLUOROPHENETHYL) -3-FLUOROALLYLAMINE
FI903604A0 (en) New Process for Preparation of 2-Diazo-3-Trisubstituted Silyloxy-3-Butenoates

Legal Events

Date Code Title Description
FG Patent granted

Owner name: HOECHST AKTIENGESELLSCHAFT

BB Publication of examined application
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT